Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yusheng Guo, Yanqiao Ren, Xiangjun Dong, Xuefeng Kan & Chuansheng Zheng. (2022) An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation. Journal of Hepatocellular Carcinoma 9, pages 343-355.
Read now
Read now
Articles from other publishers (9)
Qitao Hu, Huali Zuo, Jessica C. Hsu, Cheng Zeng, Zhou Tian, Zhouyi Sun, Weibo Cai, Zhe Tang & Weiyu Chen. (2023) The Emerging Landscape for Combating Resistance Associated with Energy‐Based Therapies via Nanomedicine. Advanced Materials.
Crossref
Crossref
Feilong Ye, Lulu Xie, Licong Liang, Zhimei Zhou, Siqin He, Rui Li, Liteng Lin & Kangshun Zhu. (2023) Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation. Journal of Interventional Medicine 6:4, pages 160-169.
Crossref
Crossref
Shilun Wu, Zhuxin Li, Changyu Yao, Shuying Dong, Jun Gao, Shan Ke, Ruhang Zhu, Sen Huang, Shaohong Wang, Li Xu, Chen Ye, Jian Kong & Wenbing Sun. (2022) Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research. Frontiers in Oncology 12.
Crossref
Crossref
Ana I. Álvarez-Mercado, Albert Caballeria-Casals, Carlos Rojano-Alfonso, Jesús Chávez-Reyes, Marc Micó-Carnero, Alfredo Sanchez-Gonzalez, Araní Casillas-Ramírez, Jordi Gracia-Sancho & Carmen Peralta. (2021) Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection. Biomedicines 9:9, pages 1158.
Crossref
Crossref
Sandeep Arora, Roberta Catania, Amir Borhani, Natally Horvat, Kathryn Fowler & Carla Harmath. (2021) HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy. Abdominal Radiology.
Crossref
Crossref
Bin Zhang, Youpeng Wang, Ziyin Zhao, Bing Han, Jinbo Yang, Yang Sun, Bingyuan Zhang, Yunjin Zang & Huashi Guan. (2021) Temperature Plays an Essential Regulatory Role in the Tumor Immune Microenvironment. Journal of Biomedical Nanotechnology 17:2, pages 169-195.
Crossref
Crossref
Jianqing Yu, George G. Chen & Paul B. S. Lai. (2020) Targeting hepatocyte growth factor/c‐mesenchymal–epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies. Medicinal Research Reviews 41:1, pages 507-524.
Crossref
Crossref
Qi Ruan, Haolu Wang, Leslie J. Burke, Kim R. Bridle, Xinxing Li, Chun‐Xia Zhao, Darrell H.G. Crawford, Michael S. Roberts & Xiaowen Liang. (2020) Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. International Journal of Cancer 147:6, pages 1519-1527.
Crossref
Crossref
Shi-Lei Zhang, Long Ma, Jun Zhao, Shu-Ping You, Xiao-Ting Ma, Xiao-Yan Ye & Tao Liu. (2019) The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation of the FAK/PI3K/Akt Signaling Pathway. Molecules 24:18, pages 3282.
Crossref
Crossref